National
Still more marriage questions for Carney
W.H. won’t say whether Obama wants marriage in Dem platform or help in state efforts
White House Press Secretary Jay Carney (Blade file photo by Michael Key)
White House Press Secretary Jay Carney faced new questions on marriage Thursday in the first time the spokesperson publicly talked to reporters following President Obama’s announcement in support of same-sex marriage.
In a press gaggle abord Air Force One en route to Seattle, Carney declined to answer inquiries on whether Obama wants to see an inclusion of same-sex marriage in the Democratic Party platform, nor would he would say whether Obama will commit to helping with efforts to pass same-sex marriage in states.
Asked whether Obama will move toward having “pro-gay marriage language in the Democratic national platform,” Carney deferred to the Democratic National Committee.
“Well, party platform issues are for the party to decide,” Carney said. “That process is underway, and I refer you to the DNC on the question about the platform.”
Carney similarly dodged in response to a question on whether Obama will be “outspoken when these issues come up in states” deliberating same-sex marriage.
“I’m not going to speculate about what he may say or statements he might issue,” Carney said. “He has on occasion made his position known on actions by individual states, most recently in North Carolina, and I’m sure that continues to be the case. That will continue to be the case.”
Evan Wolfson, president of Freedom to Marry, said in response to Carney’s answer on the Democratic platform that those crafting the document should listen the president’s endorsement of same-sex marriage on Wednesday.
“Freedom to Marry’s call for a freedom to marry plank in the Democratic Party — a call that has won huge support from former party chairs, the convention chair, leaders in Congress, 22 senators, and over 40,000 signers on our online petition — continues full force,” Wolfson said. “The Democratic Party should do what the president did so beautifully yesterday: stand for the freedom to marry.”
Wolfson similarly said the onus is on supporters or marriage equality to advance same-sex marriage throughout the nation in the wake of Obama’s endorsement.
“We know that the president’s strong voice and clear message yesterday will have an enormous and ongoing effect in helping people wrestling with this question rise to fairness,” Wolfson said. “It’s the job of all the rest of us to go out and have the conversations that he described so well as helping change his mind.”
John Aravosis, who’s gay and editor of AMERICAblog, said he’s OK with giving Obama a short break after his endorsement of same-sex marriage, but wants to see further action from the president.
“I’m happy to give the president twenty-four hours of honeymoon before I start demanding he do more on marriage, but I do think the community will expect him, and the party, to follow through on his support of same-sex marriage,” Aravosis said. “And that would mean adding marriage equality to the party platform and speaking out more aggressively against anti-gay measures in the states, including those concerning marriage.”
Carney also took questions on the web video ad the Obama campaign on Thursday hyping Obama’s newfound support of same-sex marriage and criticizing Romney for supporting a Federal Marriage Amendment and not even supporting civil unions.
A transcript of the exchange between reporters and Carney during the gaggle follows:
Q: Jay, today the Obama campaign put out a web video that’s attacking Romney on his stance on rights for same-sex couples. Given that the President just came around on this, on the issue of gay marriage yesterday, doesn’t that seem hypocritical and politically motivated more than anything?
Carney: Well, I would refer you to the campaign to talk about ads or videos that they put out. The president noted in his interview when it came up yesterday with Robin Roberts of ABC, that his opponent, Governor Romney, has a starkly different view of these issues, and a starkly different view of the policy issues, even prior to the president’s announcement yesterday that he had come to the conclusion that he personally supports same-sex marriage.
Gov. Romney is for an amendment to the U.S. Constitution that would enshrine discrimination into our founding legal document. The president thinks that’s wrong. So their positions were starkly different before yesterday.
Q: The campaign or the president —
Carney: If you want to ask the campaign about its tactics I think you ought to ask the campaign about its tactics. The president was very clear in his interview with Robin Roberts about what his personal beliefs are. The president’s record on these issues of supporting LGBT rights is long and impressive and clear, and he’ll continue to fight to expand and protect the rights of all American citizens.
Q: Can you tell us whom — after he gave his interview, to whom has the president spoken personally, both on the gay advocacy side, and also perhaps on the other side in terms of any religious leaders or people who might want to get an explanation from him about his stance?
Carney: I don’t have any conversations of the president to read out to you. The president had quite a busy day yesterday, and it continued to be busy after his interview.
Q: And do you suspect that at any point he would just point that out?
Carney: I wouldn’t — I couldn’t predict on that.
Q: Is the president excited to talk about this issue tonight now that he’s going to be doing a fundraiser in California among probably a lot of people who are very supportive of gay marriage? This is sort of the first chance he’ll have to talk about it since revealing his view.
Carney: I think the President has always been clear about his support for LGBT rights and the actions that he’s taken, including repealing “don’t ask, don’t tell”; the fact that he has long opposed the Defense of Marriage Act; the fact that he and the Attorney General, and therefore the administration, have deemed Section 3 of DOMA to be unconstitutional, and therefore the decision not to continue to defend it.
But look, the President’s focus, as I think he also said yesterday in his interview, has been and will continue to be on jobs and the economy. That’s been the — creating greater security for a middle class in this country that has been under stress for a long time, even predating the Great Recession, has been number-one priority. It was his number-one priority when he ran for office, for this office, and it has been his priority since he took the oath of office. And I think you will hear him focus on those issues just as he has — going forward, just as he has in the past.
Q: Will he move to repeal DOMA officially, and have pro-gay marriage language in the Democratic national platform?
Carney: Well, party platform issues are for the party to decide. That process is underway, and I refer you to the DNC on the question about the platform.
The president’s belief that DOMA ought to be repealed is well stated. I’m not aware of the status of the legislative efforts aimed at repeal, but the president certainly supports that and has for quite a long time. I would note that he opposed DOMA back in 1996 and has opposed it ever since.
Q: Why not repeal it?
Carney: He believes it should be repealed.
Q: But why doesn’t he push to repeal to it?
Carney: I said it every time I’ve been asked about the President’s record on the Defense of Marriage Act. I mean, it’s not a “why not” question, it’s a “yes, we know” answer.
Q: Jay, the President is saying that this is a — and the White House is saying this is a states’ issue now. But will the President be outspoken when these issues come up in states about whether they should pass or not?
Carney: I’m not going to speculate about what he may say or statements he might issue. He has on occasion made his position known on actions by individual states, most recently in North Carolina, and I’m sure that continues to be the case. That will continue to be the case.
But I can’t predict when that will take place or with regards to what state issue. The president believes it is a matter for the states. He personally believes that gay and lesbian Americans ought to be able to — who are in committed, loving relationships ought to be able to marry. But he also — and I think it’s important to note — is respectful of those who disagree. He, after all, traveled some distance to reach this personal decision, and he understands that the whole country has been considering this issue and struggling with it. And we’ve seen a remarkable evolution in the broader public with regards to LGBT rights in general, and specifically with regards to same-sex marriage.
Q: So if he respects people on the other side, why go after Romney?
Carney: You can respect somebody and strongly disagree. And he absolutely disagrees with efforts to — this is the distinction, Jim: He’s respectful of those who don’t agree with him on same-sex marriage. He vehemently disagrees with those who would act to deny Americans’ rights or act to take away rights that have been established in states. And that has been his position for quite a long time.
…
Q: Could you tell us — did he mention anything this morning at all about how he felt about the announcement yesterday or the impact it’s having so far?
Carney: I’m not going to read out internal discussions, but I think the President was glad to have the opportunity that he had yesterday to speak to the country about his views on this matter and about the journey he’s traveled on it — about the profound importance of equality, about the underlying principle that guided him as he came to this decision.
He cited the Golden Rule and the need to treat others as you would have them treat you. He spoke about sort of the three areas that affected him as he was dealing with this and thinking about it: conversations with friends and family and staff members, some of whom are in committed same-sex relationships. The effect that conversations he had with members of our armed services during the fight to repeal “don’t ask, don’t tell.” And certainly his observation of and consideration of the various ways that states have been grappling with this issue, which he spoke about during his interview.
And I think those — all of those went into the process for him — a process that was a very personal one, as he discussed yesterday in his interview.
Q: When did the president came to that conclusion? I mean, we know he said to Robin Roberts in their interview that he had already decided to publicly take this position. So did he come to the conclusion weeks ago, months ago? When was that evolution complete?
Carney: I don’t have a specific date for you. Like I said, this was a very — this was not a policy debate within the White House or the administration. This was a personal decision about his personal views. I think it’s fair to say that within the last several months he had come to the decision that he talked about yesterday and had concluded that he wanted to convey his views on this to the American people sometime in the next several weeks or months. It wasn’t going to be this week, but because of the considerable focus on the issue this week, the President decided it might as well be this week.
Q: What effect did your — the grilling you got Monday at the briefing have on his sense of expediting this? Did he say anything to you about it?
Carney: I think — part of my job, and I think it reinforced the fact that this had become an issue that was getting a great deal of attention and focus, but certainly not about me.
Federal Government
Holiday week brings setbacks for Trump-Vance trans agenda
Federal courts begin to deliver end-of-year responses to lawsuits involving federal transgender healthcare policy.
While many Americans took the week of Christmas to rest and relax, LGBTQ politics in the U.S. continued to shift. This week’s short recap of federal updates highlights two major blows to the Trump-Vance administration’s efforts to restrict gender-affirming care for minors.
19 states sue RFK Jr. to end gender-affirming care ban
New York Attorney General Letitia James announced on Tuesday that the NYAG’s office, along with 18 other states (and the District of Columbia), filed a lawsuit to stop U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. from restricting gender-affirming care for minors.
In the press release, Attorney General James stressed that the push by the Trump-Vance administration’s crusade against the transgender community — specifically transgender youth — is a “clear overreach by the federal government” and relies on conservative and medically unvalidated practices to “punish providers who adhere to well-established, evidence-based care” that support gender-affirming care.
“At the core of this so-called declaration are real people: young people who need care, parents trying to support their children, and doctors who are simply following the best medical evidence available,” said Attorney General James. “Secretary Kennedy cannot unilaterally change medical standards by posting a document online, and no one should lose access to medically necessary health care because their federal government tried to interfere in decisions that belong in doctors’ offices. My office will always stand up for New Yorkers’ health, dignity, and right to make medical decisions free from intimidation.”
The lawsuit is a direct response to HHS’ Dec. 18 announcement that it will pursue regulatory changes that would make gender-affirming health care for transgender children more difficult, if not impossible, to access. It would also restrict federal funding for any hospital that does not comply with the directive. KFF, an independent source for health policy research, polling, and journalism, found that in 2023 federal funding covered nearly 45% of total spending on hospital care in the U.S.
The HHS directive stems directly from President Donald Trump’s Jan. 28 Executive Order, Protecting Children From Chemical and Surgical Mutilation, which formally establishes U.S. opposition to gender-affirming care and pledges to end federal funding for such treatments.
The American Medical Association, the nation’s largest and most influential physician organization, has repeatedly opposed measures like the one pushed by President Trump’s administration that restrict access to trans health care.
“The AMA supports public and private health insurance coverage for treatment of gender dysphoria and opposes the denial of health insurance based on sexual orientation or gender identity,” a statement on the AMA’s website reads. “Improving access to gender-affirming care is an important means of improving health outcomes for the transgender population.”
The lawsuit also names Oregon, Washington, California, Colorado, Connecticut, Delaware, the District of Columbia, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Mexico, Pennsylvania, Rhode Island, Vermont, and Wisconsin as having joined New York in the push against restricting gender-affirming care.
At the HHS news conference last Thursday, Jim O’Neill, deputy secretary of the department, asserted, “Men are men. Men can never become women. Women are women. Women can never become men.”
DOJ stopped from gaining health care records of trans youth
U.S. District Judge Cathy Bissoon blocked an attempt by the Department of Justice (DOJ) to gain “personally identifiable information about those minor transgender patients” from the University of Pittsburgh Medical Center (UPMC), saying the DOJ’s efforts “fly in the face of the Supreme Court.”
Journalist Chris Geidner originally reported the news on Dec. 25, highlighting that the Western District of Pennsylvania judge’s decision is a major blow to the Trump-Vance administration’s agenda to curtail transgender rights.
“[T]his Court joins the others in finding that the government’s demand for deeply private and personal patient information carries more than a whiff of ill intent,” Bissoon wrote in her ruling. “This is apparent from its rhetoric.”
Bissoon cited the DOJ’s “incendiary characterization” of trans youth care on the DOJ website as proof, which calls the practice politically motivated rather than medically sound and seeks to “…mutilate children in the service of a warped ideology.” This is despite the fact that a majority of gender-affirming care has nothing to do with surgery.
In United States v. Skrmetti, the Supreme Court ruled along party lines that states — namely Tennessee — have the right to pass legislation that can prohibit certain medical treatments for transgender minors, saying the law is not subject to heightened scrutiny under the Equal Protection Clause of the Fourteenth Amendment because it does not involve suspect categories like race, national origin, alienage, and religion, which would require the government to show the law serves a compelling interest and is narrowly tailored, sending decision-making power back to the states.
“The government cannot pick and choose the aspects of Skrmetti to honor, and which to ignore,” Judge Bissoon added.
The government argued unsuccessfully that the parents of the children whose records would have been made available to the DOJ “lacked standing” because the subpoena was directed at UPMC and that they did not respond in a timely manner. Bissoon rejected the timeliness argument in particular as “disingenuous.”
Bissoon, who was nominated to the bench by then-President Obama, is at least the fourth judge to reject the DOJ’s attempted intrusion into the health care of trans youth according to Geidner.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
How to cope when a partner gives you the silent treatment
Out actor talks lead role in ‘Fiddler on the Roof’
This gay author sees dead people
Holiday week brings setbacks for Trump-Vance trans agenda
Your guide to D.C.’s queer New Year’s Eve parties
Your guide to D.C.’s queer New Year’s Eve parties
Holiday week brings setbacks for Trump-Vance trans agenda
Out actor talks lead role in ‘Fiddler on the Roof’
This gay author sees dead people
